Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin.
Caracciolo D, Juli G, Riillo C, Coricello A, Vasile F, Pollastri S, Rocca R, Scionti F, Polerà N, Grillone K, Arbitrio M, Staropoli N, Caparello B, Britti D, Loprete G, Costa G, Di Martino MT, Alcaro S, Tagliaferri P, Tassone P. Caracciolo D, et al. Among authors: britti d. J Transl Med. 2022 Oct 22;20(1):482. doi: 10.1186/s12967-022-03705-z. J Transl Med. 2022. PMID: 36273153 Free PMC article.
Editor's Note: A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.
Gullà A, Martino MTD, Cantafio MEG, Morelli E, Amodio N, Botta C, Pitari MR, Lio SG, Britti D, Stamato MA, Hideshima T, Munshi NC, Anderson KC, Tagliaferri P, Tassone P. Gullà A, et al. Among authors: britti d. Clin Cancer Res. 2024 May 15;30(10):2288. doi: 10.1158/1078-0432.CCR-24-1089. Clin Cancer Res. 2024. PMID: 38745477 No abstract available.
Retraction notice to "Glycogen synthase kinase-3β inhibition attenuates the degree of arthritis caused by type II collagen in the mouse" [Clin. Immunol. 120/1 (2006) 57-67].
Cuzzocrea S, Mazzon E, Di Paola R, Muià C, Crisafulli C, Dugo L, Collin M, Britti D, Caputi AP, Thiemermann C. Cuzzocrea S, et al. Among authors: britti d. Clin Immunol. 2024 May;262:110198. doi: 10.1016/j.clim.2024.110198. Epub 2024 Mar 29. Clin Immunol. 2024. PMID: 38555221 No abstract available.
Corrigendum to "Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation" [Biochem. Pharmacol. 119 (2016) 27-41].
Impellizzeri D, Di Paola R, Cordaro M, Gugliandolo E, Casili G, Morittu VM, Britti D, Esposito E, Cuzzocrea S. Impellizzeri D, et al. Among authors: britti d. Biochem Pharmacol. 2024 May;223:116105. doi: 10.1016/j.bcp.2024.116105. Epub 2024 Mar 20. Biochem Pharmacol. 2024. PMID: 38513506 No abstract available.
181 results